Inhibrx Biosciences, Inc. - Common Stock, par value $0.0001 per share (INBX)

CUSIP: 45720N103

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 7 signals
Share change
+2,191,004
Put/Call ratio
69%
SEC-reported price per share
$79.00
Number of holders
139
Value change
+$184,334,509
Number of buys
80
Open additional details 1 more signal available
Number of sells
46
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
14,630,961

Security key

45720N103

Report period

Q4 2025

Institutions

139

Top holders

10

Ownership snapshot

Top reported holders of INBX - Inhibrx Biosciences, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
MORGAN STANLEY
Disclosed value leader
MORGAN STANLEY
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G 13F 3/4/5 Lead comparable stake: 7.9% 13D/G row: MORGAN STANLEY Showing 1-6 of 15 holder rows.

Quick read

MORGAN STANLEY leads the comparable SEC ownership view at 7.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MORGAN STANLEY's linked filing trail.
Comparable ownership Top 5
MORGAN STANLEY 7.9%
Jon Faiz Kayyem 7.9%
Mark P. Lappe 6.4%
BlackRock, Inc. 5.3%
VIKING GLOBAL INVESTORS LP 0.7%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
MORGAN STANLEY
13D/G 13F
Company
7.9%
$84,668,884
1,155,416 shares
$0 31 Dec 2025
Jon Faiz Kayyem
13D/G
7.9%
$13,765,571
1,149,046 shares
$0 03 Jun 2024
Mark P. Lappe
3/4/5 13D/G
Chief Executive Officer, Director · Mark Lappe
6.4%
from 13D/G
$15,852,324
1,225,413 shares
mixed-class rows
12 Sep 2024
BlackRock, Inc.
13D/G 13F
Company
5.3%
$60,682,270
768,130 shares
+$6,933,198 31 Dec 2025
VIKING GLOBAL INVESTORS LP
13F 3/4/5
Company · 10%+ Owner
0.7%
from 3/4/5
$60,209,904
1,787,705 shares
30 Sep 2025
PERCEPTIVE ADVISORS LLC
13F
Company
13F
9.1%
$44,717,171
1,327,707 shares
30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
139
Shares
12,777,957
Rows available
139
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
101
Q4 2025 holders
139
Holder diff
38
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .